Savings or convenience? Why not both! Buy Diovan with us!

YARDLEY, Pa. — According to traditional total prescription (TRx) metrics, there were 2.3 million prescriptions for Diovan HCT in the second quarter of 2004. However, Verispan’s Total Patient Tracker, which measures market sizes by viewing unique patients, shows the actual number of patients who filled prescriptions for the hypertension drug during the same time period was 1.1 million–less than half the number of prescriptio…

DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/reports/c64756) has announced the addition of Novartis: Performance, Products, Pipeline and Potential to their offering.
Pharmaceutical company intelligence reports provide a ful…

The following untitled letters were issued by Center for Food Safety and Nutrition’s (CFSAN) Division of Dietary Supplement Programs Office of Nutritional Products or by Center for Drug Evaluation and Research’s Office of Medical Policy Division of Drug …

- Approvals consistent with current US treatment guidelines to start appropriate patients on combination therapies
- Up to 80% of patients may need multiple medications to help them reach blood pressure goals
- Single-pill combinations offer effective, convenient medications which could help patients reach treatment goals faster
- Diovan HCT and Exforge approvals may benefit patients who are likely to…

Atacand
(candesartan, AstraZeneca)

Most Popular
10 Jobs That Pay $30 An Hour
5 Regular Mistakes In Public Speaking
Today’s Best Part-Time Jobs
3 Questions No Job Seeker Ever Wants To Be Asked?
13 Job Interview Mistakes To Avoid

An angiotensin receptor blocker (ARB) for treating patients with heart failure (NYHA class II-IV and an ejection fraction of 40% or less), to reduce the risk of death from ca…

Byline: RUPAL PAREKH And MATTHEW CREAMER
rparekh@adage.com, mcreamer@adage.com

Related Results

…

Results have been published in The Lancet from the eagerly-awaited VALUE (Valsartan Antihypertensive Long-term Use Evaluation) trial, which compared Novartis’ angiotensin II receptor blocker Diovan (valsartan) with Pfizer’s calcium antagonist Norvasc (amlodipine) in hypertensive patients at high cardiovascular risk.

Most Popular
3 Questions No Job Seeker Ever Wants T…

Two new studies have produced mixed results for two different drugs that are often used to treat heart failure.
In the first study, researchers found limited benefit from a drug called valsartan (Diovan), which is used to lower systolic bloo…

(valsartan, Novartis)
An angiotensin receptor blocker (ARB) for treating heart failure (New York Heart Association class II-IV) in people who cannot tolerate ACE inhibitors. The first ARB approved for heart fa…

Diovan lowered the level of the inflammatory
marker high sensitivity C-reactive protein (hsCRP), independently of its
established efficacy in lowering blood pressure, according to findings
presented at the American Society of Hypertension, Inc. (ASH) Annual
Scientific Meeting and Exposition (ASH 2006) and published online in
Hypertension later today. The study also showed that Diovan and Diovan HCT
helped a significant number of hard-to-treat patients with a severe for…